查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1835471

肺动脉支架市场依产品类型、适应症、材料、病患年龄层和通路划分－全球预测，2025-2032年

Lung Stents Market by Product Type, Indication, Material, Patient Age Group, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，肺动脉支架市场规模将达到 2.3523 亿美元，复合年增长率为 8.32%。

关键市场统计数据
基准年 2024 1.2409亿美元
预计年份：2025年 1.3435亿美元
预测年份 2032 2.3523亿美元
复合年增长率 (%) 8.32%

本文展望了临床需求、材料创新和医疗系统奖励将如何共同作用，重塑肺动脉支架的研发和临床应用。

肺动脉支架可治疗多种气道疾病，从良性结构性缺陷到恶性阻塞，并且与微创介入和个人化呼吸护理的更广泛趋势日益契合。临床医生正在采用更精密的器材设计来处理复杂的支气管解剖结构，而工程师则正在应用先进的材料科学和製造技术来改善支架的输送性能、径向力分布和生物相容性。同时，支付方和医疗系统优先考虑能够减少加护治疗使用率和再入院率的治疗结果，从而奖励采用持久可靠的治疗方法，以加快患者康復并提高生活品质。

因此，肺动脉支架领域正沿着多个维度发展：人口老化和适应症扩大带来的临床需求；包括新型合金、聚合物化学和药物释放型策略在内的技术创新；以及奖励那些展现出显着手术疗效和长期安全性的器械的商业性压力。这些因素共同作用，使得可靠的临床证据、可重复的生产品质和上市后监测变得愈发重要。因此，相关人员必须整合跨职能观点——从介入性肺病学和胸腔外科到监管事务和供应链管理——才能顺利推进下一代肺动脉支架的推广应用，最终实现其为患者带来的潜在益处。

重新定义肺动脉支架生态系的竞争优势和临床预期，简明扼要地总结技术、监管和供应链的关键转变

随着材料科学、手术影像技术和患者选择方面的进步，肺动脉支架领域正在发生显着变化，这些进步正在改变气道植入的设计标准和临床预期。新型材料，例如生物可吸收聚合物和镁基支架，旨在最大限度地减少长期异物暴露，同时提供临时结构支撑，从而激发了人们对能够顺应组织癒合轨蹟的器械的兴趣。同时，内视镜视觉化、三维气道建模和植入系统的改进，正在增强我们治疗解剖结构复杂病变的能力，并降低围手术全期风险。

此外，监管和报销环境也在同步演变，监管机构日益要求提供真实世界证据和强有力的核准后监测，以检验对照试验以外的安全性。因此，製造商正在投资于註册登记基础设施和数位健康整合，以持续了解治疗结果。此外，近期全球范围内的动盪使得供应链韧性和生产扩充性成为战略重点，推动了本土化生产和更紧密的供应商合作。这些转变是结构性的，而非渐进式的，它们正在重新定义那些能够将临床证据生成、先进材料工程和敏捷商业化策略相结合，以满足新的医疗标准需求的企业的竞争优势。

本文分析了2025年美国关税改革如何改变了肺动脉支架价值链的采购经济、製造地策略和商业合约。

美国于2025年生效的关税调整对肺动脉支架供应链产生了连锁反应，反映出该产业对原料投入和成品流通贸易政策的敏感度。部分进口零件关税的提高增加了依赖全球供应商的製造商的短期到岸成本，促使采购团队重新评估筹资策略和总到岸成本的计算方法。为此，一些製造商加快了靠近终端市场的供应商的资格认证流程，并探索能够在保持临床性能的同时降低贸易费用波动风险的替代投入。

此外，关税也影响了资本部署决策，製造商需要在投资建立更多本土产能与继续依赖海外合作伙伴之间权衡利弊。虽然这种权衡往往导致短期内产品前置作业时间延长，但也为优先考虑临床应用时间和客户需求应对力的本地製造伙伴关係创造了机会。临床医生和医院的采购负责人透过合约週期和库存策略间接感受到了这些变化，许多医疗系统更倾向于选择拥有多元化製造地的供应商，以降低关税造成的供应中断风险。

此外，政策环境也影响了商业谈判和定价动态，支付方和集团采购组织呼吁提高成本驱动因素和临床价值的透明度。随着转型影响波及整个生态系统，那些制定了清晰的供应连续性计划并维持了健全品质体系的公司，获得了更牢固的采购关係。展望未来，关税事件凸显了供应链灵活性、跨司法管辖区的监管协调以及利用临床和实验室数据证明材料替代合理性的重要性，从而在控製成本的同时保障患者安全。

多层次細項分析揭示了产品类型、临床适应症、材料科学、患者人口统计特征和分销管道如何驱动不同的开发和商业化需求。

细分市场层面的动态变化揭示了不同的发展轨迹和临床应用案例，这些因素持续影响产品蓝图和商业化策略。按产品类型划分，市场包括生物可吸收支架、药物释放型、金属支架和聚合物支架。生物可吸收支架又分为镁合金支架和聚乳酸（PLLA）支架，而聚合物支架则分为可生物降解支架和不可降解支架。这些产品差异会影响临床决策，例如支架的耐久性、发炎反应以及后续干预的必要性，从而引导研发重点转向径向强度、可控吸收曲线以及符合人体工学的输送系统最佳化。从器械配置到临床应用，基于适应症的细分涵盖了气道阻塞、恶性肿瘤、气管支气管狭窄和肿瘤相关用途，其中肿瘤适应症进一步细分为良性和恶性亚型。每种适应症都面临独特的操作挑战和监管证据要求，因此需要製定客製化的研究设计和差异化的上市后监测计画。

以聚合物为基础的材料进一步细分为聚左旋乳酸和聚碳酸酯胺甲酸乙酯两大类，每类材料都有不同的机械性能和生物相容性。这些材料层面的权衡取舍会影响临床医师的偏好和生产的复杂性，进而影响灭菌方案和保存期限。患者人群的细分也需要关注。成人、老年和儿童患者对产品尺寸、柔韧性和长期安全性的要求各不相同，这会影响标籤策略和儿科临床试验的发展。最后，门诊手术中心、诊所和医院等分销管道的细分会影响市场策略、服务模式和培训项目。门诊机构通常优先考虑库存精简和快速週转，而医院系统则强调全方位服务支援、广泛的临床培训以及与多学科气道团队的整合。这些细緻的细分洞察综合起来，揭示了开发人员和商业团队必须如何调整产品设计、临床证据和通路策略，以满足不同医疗机构和病患小组的细微需求。

对美洲、欧洲、中东和非洲以及亚太地区的临床实践、监管复杂性和采购重点进行细緻评估，将有助于制定推广路径。

区域动态决定了医疗器材製造商和服务供应商在临床、监管和商业性的不同优先事项，进而影响其策略规划。在美洲，医疗保健系统优先考虑能够证明手术有效性和长期安全性的证据，而供应链的韧性和本土製造能力也日益成为采购决策的重要因素。这些因素推动了对拥有完善临床註册和可预测服务模式的医疗器材的需求。相反，欧洲、中东和非洲地区（EMEA）多样化的监管和报销环境要求製造商调整打入市场策略，他们通常需要寻求有针对性的核准和本地合作伙伴关係，以应对分散的卫生技术评估（HTA）流程和多样化的临床实践模式。

亚太地区在三级医疗机构中持续快速地推广微创呼吸治疗技术，这主要得益于对微创呼吸治疗的投资以及受过专业训练的介入医师数量的增加。在此背景下，价格敏感度和对可扩展生产解决方案的需求将影响商业化策略，而区域伙伴关係和授权协议则可能加速该技术惠及更广泛的患者群体。在这些全部区域。

关键的公司层面影响因素，重点阐述了临床证据、卓越的製造流程、智慧财产权和合作伙伴关係将如何决定肺动脉支架领域的竞争地位。

主要企业之间的竞争优势在于透过创新、临床证据的累积以及推动市场准入和医保报销的策略联盟实现差异化。市场领导者大力投资于器械的迭代改进，并在多个司法管辖区获得监管部门的核准，同时开展註册研究和上市后研究以证明其产品具有相对优势。同时，规模较小的创新企业透过开发专用支架或新型药物洗脱平台来开闢利基市场，它们通常与大型製造商在销售和联合开发方面开展合作，以高效地扩大商业规模。智慧财产权组合仍然是至关重要的资产，专利策略保护着支撑临床差异化的关键材料配方、支架结构和递送机制。

同时，各公司越来越重视整合卓越的製造流程和品质体系，以满足严格的上市后监管要求，并缩短医院供应链的补货週期。与契约製造建立策略联盟，并投资于近市场生产能力，正成为能够提供可靠前置作业时间和区域监管合规性的公司的差异化优势。此外，整合先进影像相容性、手术规划软体和结果追踪平台等数位化工具的公司，透过降低学习门槛和实现数据主导的术后随访，提高了临床医生的接受度。综上所述，这些竞争措施表明，成功的公司将是那些能够将可靠的临床数据、可扩展的製造能力和增值服务相结合，以满足不断变化的相关人员期望的公司。

提出切实可行的策略建议，以协调产品开发、实证项目、供应链韧性和商业模式，从而加速临床应用和市场准入。

为了有效掌握临床和商业机会，产业领导者应采取整合策略，协调产品创新、证据产生和供应链韧性。首先，应优先考虑将材料选择和器械架构与明确定义的适应症和患者群体相匹配的研发路径，以降低监管复杂性并促进临床医生接受。同时，应投资于早期和持续的真实世界证据项目，以补充关键性试验，因为持续的洞察有助于加强医保报销谈判并支持器械的迭代改进。此外，加强与策略供应商的关係并实现製造地多元化，可以降低关税和物流风险，同时加快对临床需求的反应速度。

此外，应拓展商业模式，超越产品销售的范畴，涵盖临床培训、流程支援和数位化结果工具，以降低门诊和住院环境中的应用门槛。寻求在地化的伙伴关係，以应对监管和报销环境的差异，并在必要时考虑许可和联合开发，以加速市场拓展，从而适应当地的临床实践和价格敏感度。最后，应维持积极主动的监管沟通策略，预判上市后的预期，并以透明的方式应对安全讯号。透过执行这些协调一致的行动，企业领导者可以增强其对临床医生、支付者和采购机构的价值提案，同时为其产品组合的永续长期应用奠定基础。

采用透明的混合方法研究途径，结合专家访谈、文件分析和资料三角验证，以检验临床、技术和商业性发现，并找出证据缺口。

本分析所依据的研究采用了混合方法，结合了初步的定性研究和严谨的二手研究，以确保对临床、技术和商业性方面有全面的了解。初步研究工作包括对介入性肺科医生、胸腔外科医生、器械开发人员、采购负责人和监管专家进行结构化访谈，以获取关于手术需求、材料性能和采购标准的第一手观点。透过查阅临床文献、器械註册资讯、监管申报文件和技术评​​估报告，检验了从这些访谈中得出的假设，从而支持了相关人员访谈中提出的安全性和性能主题。

资料综合分析采用多资讯来源三角验证法，以检验关键发现并最大限度地减少单一资讯来源偏差，特别关注设备设计特征、材料科学发展以及上市后监测趋势。调查方法还纳入了对供应链脆弱性和政策变化的分析，利用公开的贸易和监管记录来阐明关税和製造商应对措施的影响。因此，对于存在不确定性的领域，研究重点指出了需要进一步进行一手研究或纵向註册追踪的方面。调查方法的透明度使读者能够评估证据的强度，并识别需要进一步调查或进行针对性临床研究的空白领域。

对各项结论的全面回顾表明，整合证据产生、生产韧性和协作商业模式将决定肺动脉支架未来应用的发展轨迹。

肺动脉支架领域正处于曲折点，材料创新、手术技术进步以及不断变化的采购动态将共同影响哪些技术最终能够获得临床认可。将设计改进与可衡量的患者获益联繫起来，需要对临床证据、生产可靠性以及上市后结果的了解进行协同投资。此外，近期政策的变化和供应链压力凸显了多元化采购和监管灵活性在营运中的重要性。在相关人员应对这一复杂局面的过程中，那些能够将严谨的临床数据生成与适应性生产和精准的商业策略相结合的企业，将更有利于实现持续的临床价值和组织发展。

总之，肺动脉支架的广泛应用不仅取决于其技术性能，还取决于可证实的患者疗效、稳定的供应以及与医疗保健系统支付和采购框架的契合度。製造商、临床医生和采购方携手合作，共同製定循证标准、提供培训和生命週期支持，可以加速肺动脉支架在不断扩大的适应症和医疗环境中的安全有效应用，最终改善患者的呼吸功能和手术效率。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 药物释放型气道支架在标靶肺部药物传递的应用日益广泛
  • 开发可生物降解的肺动脉支架以减少长期併发症
  • 整合先进的影像引导系统以实现支架的精准放置
  • 在复杂解剖结构中越来越多地使用患者特异性3D列印气道支架
  • 抗菌涂层支架可预防植入后感染
  • 新一代生物可吸收肺动脉支架在主要市场获得监管部门核准
  • 自膨式金属支架的技术进步可实现最佳气道通畅性
  • 一项评估新型生物可吸收气道支架治疗严重气管狭窄的临床试验
  • 支架製造商和生物技术公司在材料创新方面合作
  • 兼具药物释放型和径向力支撑功能的双用途气道支架的市场渗透率

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 肺动脉支架市场（依产品类型划分）

  • 生物可吸收支架
    • 镁基
    • 基于PLLA的
  • 药物释放型支架
  • 金属支架
  • 聚合物支架
    • 可生物降解
    • 不可降解

9. 依适应症分類的肺动脉支架市场

  • 气道阻塞
  • 马拉西亚
  • 支气管狭窄
  • 瘤
    • 良性肿瘤
    • 恶性肿瘤

第十章 肺动脉支架市场（依材料分类）

  • 镍钛诺
  • 聚合物基
    • 聚左旋乳酸
    • 聚碳酸酯胺甲酸乙酯
  • 不銹钢

第十一章 依病患年龄组别分類的肺动脉支架市场

  • 成人
  • 老年人
  • 孩子们

第十二章 肺动脉支架市场（依通路划分）

  • 门诊手术中心
  • 诊所
  • 医院

第十三章 肺动脉支架市场（依地区划分）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 肺动脉支架市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国肺动脉支架市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Boston Scientific Corporation
    • Medtronic plc
    • Cook Medical LLC
    • WL Gore & Associates, Inc.
    • Taewoong Medical Co., Ltd
    • Merit Medical Systems, Inc.
    • Novatech SA
    • Meril Life Sciences Pvt. Ltd
    • Stening SRL
    • BVM Medical Limited
Product Code: MRR-437A5D08AE43

The Lung Stents Market is projected to grow by USD 235.23 million at a CAGR of 8.32% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 124.09 million
Estimated Year [2025] USD 134.35 million
Forecast Year [2032] USD 235.23 million
CAGR (%) 8.32%

A forward-looking introduction that frames how clinical demand, materials innovation, and health system incentives converge to reshape lung stent development and clinical adoption

Lung stents address a spectrum of airway pathologies that range from benign structural weakness to malignant obstruction, and they increasingly intersect with broader trends in minimally invasive intervention and personalized respiratory care. Clinicians are adopting more sophisticated device designs to manage complex tracheobronchial anatomies, while engineers apply advanced materials science and manufacturing techniques to improve deliverability, radial force profiles, and biocompatibility. At the same time, payers and health systems emphasize outcomes that reduce intensive care utilization and rehospitalization, thereby creating incentives for durable, reliable interventions that shorten recovery and improve quality of life.

Consequently, the landscape for lung stents is evolving along multiple axes: clinical demand driven by aging populations and expanded indications; technical innovation encompassing novel alloys, polymer chemistries, and drug elution strategies; and commercial pressures that reward devices demonstrating clear procedural efficiencies and long-term safety. These converging factors have heightened the importance of robust clinical evidence, reproducible manufacturing quality, and post-market surveillance. As a result, stakeholders must integrate cross-functional perspectives-from interventional pulmonology and thoracic surgery to regulatory affairs and supply chain management-to navigate adoption pathways and realize the potential patient benefits of next-generation lung stents.

A concise synthesis of pivotal technological, regulatory, and supply chain shifts that are redefining competitive advantages and clinical expectations across the lung stent ecosystem

The lung stent landscape is experiencing transformative shifts as advances in materials science, procedural imaging, and patient selection converge to change both the design criteria and clinical expectations for airway implants. Newer materials such as bioresorbable polymers and magnesium-based scaffolds aim to minimize long-term foreign body exposure while providing temporary structural support, and these options have catalyzed interest in devices that align with tissue healing trajectories. Simultaneously, improvements in endoscopic visualization, three-dimensional airway modeling, and deployment systems have expanded the ability to treat anatomically complex lesions with greater precision and lower perioperative risk.

Moreover, the regulatory and reimbursement environment is evolving in parallel, with authorities increasingly demanding real-world evidence and robust post-approval monitoring to validate safety profiles outside controlled trials. As a consequence, manufacturers are investing in registry infrastructure and digital health integrations to capture outcomes continuously. In addition, supply chain resilience and manufacturing scalability have risen as strategic priorities after recent global disruptions, prompting onshoring initiatives and closer supplier partnerships. Together, these shifts are not incremental but structural: they redefine competitive advantages toward organizations that can combine clinical evidence generation, advanced materials engineering, and agile commercialization strategies to meet the new standard of care.

An analytical review of how United States tariff reforms in 2025 altered sourcing economics, manufacturing location strategy, and commercial contracting across the lung stent value chain

The United States tariff adjustments enacted in 2025 have produced cascading effects across the lung stent supply chain, reflecting the industry's sensitivity to trade policy on both raw material inputs and finished device flows. Increased tariffs on select imported components raised immediate landed costs for manufacturers reliant on global suppliers, prompting procurement teams to reassess sourcing strategies and total landed cost calculations. In response, some producers accelerated supplier qualification programs closer to end markets and explored alternative inputs that preserve clinical performance while reducing exposure to volatile trade fees.

In addition, tariffs influenced capital deployment decisions, as manufacturers weighed the economics of incremental onshore capacity investments against continued reliance on international partners. This rebalancing often extended product lead times in the near term while creating opportunities for localized manufacturing partnerships that prioritize time-to-clinic and responsiveness to customer demand. Clinicians and hospital purchasers felt these changes indirectly through contracting cycles and inventory strategies, leading many health systems to prefer suppliers with diversified manufacturing footprints that could mitigate tariff-driven supply disruptions.

Furthermore, the policy environment shaped commercial negotiations and pricing dynamics, with payers and group purchasing organizations seeking greater transparency on cost drivers and clinical value. As transitional effects rippled through the ecosystem, companies that communicated clear supply continuity plans and maintained robust quality systems experienced stronger procurement relationships. Looking ahead, the tariff episode underscored the strategic importance of supply chain flexibility, regulatory harmonization across jurisdictions, and the capacity to justify material substitutions through clinical and bench data to preserve patient safety while controlling costs.

A multilayered segmentation analysis revealing how product type, clinical indication, material science, patient demographics, and distribution channels drive distinct development and commercialization imperatives

Segment-level dynamics reveal distinct development trajectories and clinical use-cases that continue to shape product road maps and commercialization strategies. Based on product type, the market includes bioresorbable stents, drug-eluting stents, metallic stents, and polymer stents, with bioresorbable options further differentiated into magnesium-based and PLLA-based designs and polymer stents categorized into biodegradable and nondegradable variants. These product distinctions influence clinical decision-making around durability, inflammatory response, and the need for subsequent interventions, and they guide R&D priorities toward optimizing radial strength, controlled resorption profiles, and delivery system ergonomics. Transitioning from device composition to clinical application, the indication-based segmentation captures airway obstruction, malacia, tracheobronchial stenosis, and tumor-related uses, with tumor indications further divided into benign and malignant subtypes. Each indication presents unique procedural challenges and regulatory evidence expectations, prompting tailored trial designs and differentiated post-market surveillance plans.

Material choice further intersects with performance objectives, with options spanning nitinol, polymer-based constructs, and stainless steel; polymer-based materials are further subdivided into poly-L-lactic acid and polycarbonate urethane variants that each bring different mechanical and biocompatibility profiles. These material-level trade-offs factor into both clinician preference and manufacturing complexity, affecting sterilization protocols and shelf-life considerations. Patient age group segmentation also merits attention, as adults, geriatric patients, and pediatric populations demand different sizing, flexibility, and long-term safety profiles, thereby influencing labeling strategies and pediatric study commitments. Finally, distribution channel segmentation across ambulatory surgical centers, clinics, and hospitals shapes go-to-market approaches, service models, and training programs; ambulatory settings often prioritize streamlined inventory and rapid turnover, whereas hospital systems emphasize full-service support, robust clinical training, and integration with multidisciplinary airway teams. Taken together, these granular segmentation insights highlight how developers and commercial teams must align product design, clinical evidence, and channel strategy to match the nuanced needs encountered across practice settings and patient groups.

A nuanced regional assessment of clinical practices, regulatory complexity, and procurement priorities across the Americas, Europe Middle East & Africa, and Asia-Pacific that shape adoption pathways

Regional dynamics impose distinct clinical, regulatory, and commercial priorities that influence strategic planning for device manufacturers and service providers. In the Americas, health systems emphasize evidence demonstrating procedural efficiency and long-term safety, while supply chain resilience and domestic manufacturing increasingly shape procurement decisions; these factors drive demand for devices supported by extensive clinical registries and predictable service models. Conversely, Europe, Middle East & Africa presents a heterogeneous landscape in which varied regulatory frameworks and reimbursement environments require adaptive market entry strategies; manufacturers often pursue targeted approvals and local partnerships to address fragmented HTA processes and diverse clinical practice patterns.

The Asia-Pacific region continues to show rapid clinical adoption in tertiary centers, propelled by investments in minimally invasive respiratory care and a growing base of trained interventional clinicians. In that context, price sensitivity and the need for scalable manufacturing solutions influence commercialization strategies, and regional partnerships or licensing arrangements can accelerate access to broader patient populations. Across these geographies, transitional factors such as local clinical training programs, reimbursement pathway clarity, and supply chain localization efforts shape adoption speed. Therefore, successful regional strategies combine robust clinical evidence, regulatory acumen, and distribution models tailored to the operational rhythms and procurement priorities of each territory.

Key company-level implications emphasizing how clinical evidence, manufacturing excellence, intellectual property, and collaborative partnerships determine competitive positioning in the lung stent arena

Competitive dynamics among leading companies center on differentiation through technological innovation, clinical evidence generation, and strategic collaborations that accelerate access and reimbursement. Market leaders invest heavily in iterative device refinement, securing regulatory approvals across multiple jurisdictions while building registries and post-marketing studies to demonstrate comparative performance. At the same time, smaller innovators carve niches by developing specialized stents or novel drug-elution platforms, and they frequently partner with larger manufacturers for distribution or co-development to scale commercialization efficiently. Intellectual property portfolios remain a critical asset, with patent strategies protecting key material formulations, scaffold architectures, and delivery mechanisms that underpin clinical differentiation.

In parallel, companies are placing greater emphasis on manufacturing excellence and quality system integration to meet intensified post-market scrutiny and to shorten time-to-replenishment in hospital supply chains. Strategic alliances with contract manufacturers and investments in near-market production capability have emerged as distinguishing capabilities for firms that can offer dependable lead times and regulatory compliance across regions. Additionally, firms that integrate digital tools-such as advanced imaging compatibility, procedure planning software, and outcomes-tracking platforms-enhance clinician adoption by lowering the learning curve and enabling data-driven post-procedural follow-up. Collectively, these competitive behaviors suggest that successful companies will be those that combine robust clinical data, scalable manufacturing, and value-added service offerings to meet evolving stakeholder expectations.

Actionable strategic recommendations that align product development, evidence programs, supply chain resilience, and commercial models to accelerate clinical adoption and market access

Industry leaders should adopt an integrated strategy that synchronizes product innovation, evidence generation, and supply chain resilience to capture clinical and commercial opportunities effectively. First, prioritize development pathways that align material selection and device architecture with clearly defined indications and patient cohorts to reduce regulatory complexity and enhance clinician uptake. Simultaneously, invest in early and sustained real-world evidence programs that complement pivotal studies, as continuous outcome capture strengthens reimbursement negotiations and supports iterative device improvement. Moreover, enhancing relationships with strategic suppliers and diversifying manufacturing footprints will mitigate tariff and logistics risks while shortening response times to clinical demand.

In addition, expand commercial models beyond product sales to include clinical training, procedural support, and digital outcomes tools that lower barriers to adoption in both ambulatory and hospital settings. Pursue targeted regional partnerships to navigate heterogeneous regulatory and reimbursement landscapes, and consider licensing or co-development arrangements to accelerate market entry where local clinical practice or price sensitivity requires adaptation. Finally, maintain a proactive regulatory engagement strategy that anticipates post-market surveillance expectations and addresses safety signals transparently. By executing these coordinated actions, leaders can strengthen their value propositions for clinicians, payers, and procurement organizations while positioning their portfolios for sustainable long-term adoption.

A transparent mixed-methods research approach combining expert interviews, document analysis, and data triangulation to validate clinical, technical, and commercial findings and identify evidence gaps

The research underlying this analysis employed a mixed-methods approach combining primary qualitative engagement and rigorous secondary review to ensure comprehensive insight into clinical, technical, and commercial dimensions. Primary efforts included structured interviews with interventional pulmonologists, thoracic surgeons, device developers, procurement officers, and regulatory specialists to capture firsthand perspectives on procedural needs, material performance, and purchasing criteria. These conversations informed hypotheses that were then tested through a targeted review of clinical literature, device registries, regulatory filings, and technology assessment reports to corroborate safety and performance themes emerging from stakeholder interviews.

Data synthesis relied on triangulation across sources to validate key findings and minimize single-source bias, with particular attention to device design characteristics, material science developments, and post-market surveillance trends. The methodology also incorporated analysis of supply chain vulnerabilities and policy shifts, using public trade and regulatory records to contextualize tariff impacts and manufacturing responses. Limitations include variability in practice patterns across regions and the evolving nature of clinical evidence for novel materials; consequently, where uncertainty exists, the analysis highlights areas requiring additional primary study or extended registry follow-up. Transparency in methodology allows readers to assess the strength of evidence and to identify gaps that warrant further investigation or targeted clinical research.

A concluding synthesis emphasizing that integrated evidence generation, manufacturing resilience, and collaborative commercial models will determine the future trajectory of lung stent adoption

The lung stent field stands at an inflection point where material innovation, procedural advances, and evolving procurement dynamics collectively influence which technologies will gain traction in clinical practice. Translating design improvements into measurable patient benefit requires coordinated investments in clinical evidence, manufacturing reliability, and post-market outcome capture. Moreover, recent policy shifts and supply chain pressures have underscored the operational importance of diversified sourcing and regulatory agility. As stakeholders navigate these complexities, those who integrate rigorous clinical data generation with adaptable manufacturing and targeted commercial strategies will be best positioned to deliver sustained clinical value and organizational growth.

In conclusion, the pathway to broader adoption depends not only on technical performance but also on demonstrable patient outcomes, seamless supply continuity, and alignment with the payment and procurement frameworks that govern health systems. Manufacturers, clinicians, and purchasers who collaborate on evidence standards, training, and lifecycle support can accelerate safe and effective use of lung stents across a widening range of indications and care settings, ultimately improving patient respiratory outcomes and procedural efficiency.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of drug eluting airway stents for targeted pulmonary drug delivery
  • 5.2. Development of biodegradable lung stents to reduce long term complications
  • 5.3. Integration of advanced imaging guidance systems for precise stent placement
  • 5.4. Growing use of patient specific 3D printed airway stents in complex anatomies
  • 5.5. Emergence of anti microbial coated stents to prevent post implantation infections
  • 5.6. Regulatory approvals of next generation bioresorbable pulmonary stents in key markets
  • 5.7. Technological advances in self expanding metallic stents for optimal airway patency
  • 5.8. Clinical trials evaluating novel bioabsorbable airway stents in severe tracheal stenosis
  • 5.9. Collaborations between stent manufacturers and biotech firms for material innovation
  • 5.10. Market penetration of dual purpose airway stents combining drug elution and radial force support

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Lung Stents Market, by Product Type

  • 8.1. Bioresorbable Stents
    • 8.1.1. Magnesium-Based
    • 8.1.2. PLLA-Based
  • 8.2. Drug-Eluting Stents
  • 8.3. Metallic Stents
  • 8.4. Polymer Stents
    • 8.4.1. Biodegradable
    • 8.4.2. Nondegradable

9. Lung Stents Market, by Indication

  • 9.1. Airway Obstruction
  • 9.2. Malacia
  • 9.3. Tracheobronchial Stenosis
  • 9.4. Tumor
    • 9.4.1. Benign Tumor
    • 9.4.2. Malignant Tumor

10. Lung Stents Market, by Material

  • 10.1. Nitinol
  • 10.2. Polymer-Based
    • 10.2.1. Poly-L-Lactic Acid
    • 10.2.2. Polycarbonate Urethane
  • 10.3. Stainless Steel

11. Lung Stents Market, by Patient Age Group

  • 11.1. Adult
  • 11.2. Geriatric
  • 11.3. Pediatric

12. Lung Stents Market, by Distribution Channel

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Clinics
  • 12.3. Hospitals

13. Lung Stents Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Lung Stents Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Lung Stents Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Boston Scientific Corporation
    • 16.3.2. Medtronic plc
    • 16.3.3. Cook Medical LLC
    • 16.3.4. W. L. Gore & Associates, Inc.
    • 16.3.5. Taewoong Medical Co., Ltd
    • 16.3.6. Merit Medical Systems, Inc.
    • 16.3.7. Novatech SA
    • 16.3.8. Meril Life Sciences Pvt. Ltd
    • 16.3.9. Stening SRL
    • 16.3.10. BVM Medical Limited

LIST OF FIGURES

  • FIGURE 1. GLOBAL LUNG STENTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL LUNG STENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL LUNG STENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL LUNG STENTS MARKET SIZE, BY INDICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL LUNG STENTS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL LUNG STENTS MARKET SIZE, BY MATERIAL, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL LUNG STENTS MARKET SIZE, BY MATERIAL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL LUNG STENTS MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL LUNG STENTS MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL LUNG STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL LUNG STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL LUNG STENTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS LUNG STENTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA LUNG STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA LUNG STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA LUNG STENTS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE LUNG STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST LUNG STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA LUNG STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC LUNG STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL LUNG STENTS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN LUNG STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC LUNG STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION LUNG STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS LUNG STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 LUNG STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO LUNG STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL LUNG STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. LUNG STENTS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. LUNG STENTS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. LUNG STENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL LUNG STENTS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL LUNG STENTS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL LUNG STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL LUNG STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL LUNG STENTS MARKET SIZE, BY BIORESORBABLE STENTS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL LUNG STENTS MARKET SIZE, BY BIORESORBABLE STENTS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL LUNG STENTS MARKET SIZE, BY BIORESORBABLE STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL LUNG STENTS MARKET SIZE, BY BIORESORBABLE STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL LUNG STENTS MARKET SIZE, BY BIORESORBABLE STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL LUNG STENTS MARKET SIZE, BY BIORESORBABLE STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL LUNG STENTS MARKET SIZE, BY BIORESORBABLE STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL LUNG STENTS MARKET SIZE, BY BIORESORBABLE STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL LUNG STENTS MARKET SIZE, BY MAGNESIUM-BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL LUNG STENTS MARKET SIZE, BY MAGNESIUM-BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL LUNG STENTS MARKET SIZE, BY MAGNESIUM-BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL LUNG STENTS MARKET SIZE, BY MAGNESIUM-BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL LUNG STENTS MARKET SIZE, BY MAGNESIUM-BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL LUNG STENTS MARKET SIZE, BY MAGNESIUM-BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL LUNG STENTS MARKET SIZE, BY PLLA-BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL LUNG STENTS MARKET SIZE, BY PLLA-BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL LUNG STENTS MARKET SIZE, BY PLLA-BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL LUNG STENTS MARKET SIZE, BY PLLA-BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL LUNG STENTS MARKET SIZE, BY PLLA-BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL LUNG STENTS MARKET SIZE, BY PLLA-BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL LUNG STENTS MARKET SIZE, BY DRUG-ELUTING STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL LUNG STENTS MARKET SIZE, BY DRUG-ELUTING STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL LUNG STENTS MARKET SIZE, BY DRUG-ELUTING STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL LUNG STENTS MARKET SIZE, BY DRUG-ELUTING STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL LUNG STENTS MARKET SIZE, BY DRUG-ELUTING STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL LUNG STENTS MARKET SIZE, BY DRUG-ELUTING STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL LUNG STENTS MARKET SIZE, BY METALLIC STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL LUNG STENTS MARKET SIZE, BY METALLIC STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL LUNG STENTS MARKET SIZE, BY METALLIC STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL LUNG STENTS MARKET SIZE, BY METALLIC STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL LUNG STENTS MARKET SIZE, BY METALLIC STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL LUNG STENTS MARKET SIZE, BY METALLIC STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL LUNG STENTS MARKET SIZE, BY POLYMER STENTS, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL LUNG STENTS MARKET SIZE, BY POLYMER STENTS, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL LUNG STENTS MARKET SIZE, BY POLYMER STENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL LUNG STENTS MARKET SIZE, BY POLYMER STENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL LUNG STENTS MARKET SIZE, BY POLYMER STENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL LUNG STENTS MARKET SIZE, BY POLYMER STENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL LUNG STENTS MARKET SIZE, BY POLYMER STENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL LUNG STENTS MARKET SIZE, BY POLYMER STENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL LUNG STENTS MARKET SIZE, BY BIODEGRADABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL LUNG STENTS MARKET SIZE, BY BIODEGRADABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL LUNG STENTS MARKET SIZE, BY BIODEGRADABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL LUNG STENTS MARKET SIZE, BY BIODEGRADABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL LUNG STENTS MARKET SIZE, BY BIODEGRADABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL LUNG STENTS MARKET SIZE, BY BIODEGRADABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL LUNG STENTS MARKET SIZE, BY NONDEGRADABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL LUNG STENTS MARKET SIZE, BY NONDEGRADABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL LUNG STENTS MARKET SIZE, BY NONDEGRADABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL LUNG STENTS MARKET SIZE, BY NONDEGRADABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL LUNG STENTS MARKET SIZE, BY NONDEGRADABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL LUNG STENTS MARKET SIZE, BY NONDEGRADABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL LUNG STENTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL LUNG STENTS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL LUNG STENTS MARKET SIZE, BY AIRWAY OBSTRUCTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL LUNG STENTS MARKET SIZE, BY AIRWAY OBSTRUCTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL LUNG STENTS MARKET SIZE, BY AIRWAY OBSTRUCTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL LUNG STENTS MARKET SIZE, BY AIRWAY OBSTRUCTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL LUNG STENTS MARKET SIZE, BY AIRWAY OBSTRUCTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL LUNG STENTS MARKET SIZE, BY AIRWAY OBSTRUCTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL LUNG STENTS MARKET SIZE, BY MALACIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL LUNG STENTS MARKET SIZE, BY MALACIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL LUNG STENTS MARKET SIZE, BY MALACIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL LUNG STENTS MARKET SIZE, BY MALACIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL LUNG STENTS MARKET SIZE, BY MALACIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL LUNG STENTS MARKET SIZE, BY MALACIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL LUNG STENTS MARKET SIZE, BY TRACHEOBRONCHIAL STENOSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL LUNG STENTS MARKET SIZE, BY TRACHEOBRONCHIAL STENOSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL LUNG STENTS MARKET SIZE, BY TRACHEOBRONCHIAL STENOSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL LUNG STENTS MARKET SIZE, BY TRACHEOBRONCHIAL STENOSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL LUNG STENTS MARKET SIZE, BY TRACHEOBRONCHIAL STENOSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL LUNG STENTS MARKET SIZE, BY TRACHEOBRONCHIAL STENOSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL LUNG STENTS MARKET SIZE, BY TUMOR, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL LUNG STENTS MARKET SIZE, BY TUMOR, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL LUNG STENTS MARKET SIZE, BY TUMOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL LUNG STENTS MARKET SIZE, BY TUMOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL LUNG STENTS MARKET SIZE, BY TUMOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL LUNG STENTS MARKET SIZE, BY TUMOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL LUNG STENTS MARKET SIZE, BY TUMOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL LUNG STENTS MARKET SIZE, BY TUMOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL LUNG STENTS MARKET SIZE, BY BENIGN TUMOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL LUNG STENTS MARKET SIZE, BY BENIGN TUMOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL LUNG STENTS MARKET SIZE, BY BENIGN TUMOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL LUNG STENTS MARKET SIZE, BY BENIGN TUMOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL LUNG STENTS MARKET SIZE, BY BENIGN TUMOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL LUNG STENTS MARKET SIZE, BY BENIGN TUMOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL LUNG STENTS MARKET SIZE, BY MALIGNANT TUMOR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL LUNG STENTS MARKET SIZE, BY MALIGNANT TUMOR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL LUNG STENTS MARKET SIZE, BY MALIGNANT TUMOR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL LUNG STENTS MARKET SIZE, BY MALIGNANT TUMOR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL LUNG STENTS MARKET SIZE, BY MALIGNANT TUMOR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL LUNG STENTS MARKET SIZE, BY MALIGNANT TUMOR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL LUNG STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL LUNG STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL LUNG STENTS MARKET SIZE, BY NITINOL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL LUNG STENTS MARKET SIZE, BY NITINOL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL LUNG STENTS MARKET SIZE, BY NITINOL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL LUNG STENTS MARKET SIZE, BY NITINOL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL LUNG STENTS MARKET SIZE, BY NITINOL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL LUNG STENTS MARKET SIZE, BY NITINOL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL LUNG STENTS MARKET SIZE, BY POLYMER-BASED, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL LUNG STENTS MARKET SIZE, BY POLYMER-BASED, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL LUNG STENTS MARKET SIZE, BY POLYMER-BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL LUNG STENTS MARKET SIZE, BY POLYMER-BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL LUNG STENTS MARKET SIZE, BY POLYMER-BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL LUNG STENTS MARKET SIZE, BY POLYMER-BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL LUNG STENTS MARKET SIZE, BY POLYMER-BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL LUNG STENTS MARKET SIZE, BY POLYMER-BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL LUNG STENTS MARKET SIZE, BY POLY-L-LACTIC ACID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL LUNG STENTS MARKET SIZE, BY POLY-L-LACTIC ACID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL LUNG STENTS MARKET SIZE, BY POLY-L-LACTIC ACID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL LUNG STENTS MARKET SIZE, BY POLY-L-LACTIC ACID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL LUNG STENTS MARKET SIZE, BY POLY-L-LACTIC ACID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL LUNG STENTS MARKET SIZE, BY POLY-L-LACTIC ACID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL LUNG STENTS MARKET SIZE, BY POLYCARBONATE URETHANE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL LUNG STENTS MARKET SIZE, BY POLYCARBONATE URETHANE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL LUNG STENTS MARKET SIZE, BY POLYCARBONATE URETHANE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL LUNG STENTS MARKET SIZE, BY POLYCARBONATE URETHANE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL LUNG STENTS MARKET SIZE, BY POLYCARBONATE URETHANE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL LUNG STENTS MARKET SIZE, BY POLYCARBONATE URETHANE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL LUNG STENTS MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL LUNG STENTS MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL LUNG STENTS MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL LUNG STENTS MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL LUNG STENTS MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL LUNG STENTS MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL LUNG STENTS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL LUNG STENTS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL LUNG STENTS MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL LUNG STENTS MARKET SIZE, BY ADULT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL LUNG STENTS MARKET SIZE, BY ADULT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL LUNG STENTS MARKET SIZE, BY ADULT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL LUNG STENTS MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL LUNG STENTS MARKET SIZE, BY ADULT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL LUNG STENTS MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL LUNG STENTS MARKET SIZE, BY GERIATRIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL LUNG STENTS MARKET SIZE, BY GERIATRIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL LUNG STENTS MARKET SIZE, BY GERIATRIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL LUNG STENTS MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL LUNG STENTS MARKET SIZE, BY GERIATRIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL LUNG STENTS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL LUNG STENTS MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL LUNG STENTS MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL LUNG STENTS MARKET SIZE, BY PEDIATRIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL LUNG STENTS MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL LUNG STENTS MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL LUNG STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL LUNG STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL LUNG STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL LUNG STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL LUNG STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL LUNG STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL LUNG STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL LUNG STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL LUNG STENTS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL LUNG STENTS MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL LUNG STENTS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL LUNG STENTS MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL LUNG STENTS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL LUNG STENTS MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL LUNG STENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL LUNG STENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL LUNG STENTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL LUNG STENTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL LUNG STENTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL LUNG STENTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL LUNG STENTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL LUNG STENTS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 175. AMERICAS LUNG STENTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 176. AMERICAS LUNG STENTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 177. AMERICAS LUNG STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 178. AMERICAS LUNG STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 179. AMERICAS LUNG STENTS MARKET SIZE, BY BIORESORBABLE STENTS, 2018-2024 (USD MILLION)
  • TABLE 180. AMERICAS LUNG STENTS MARKET SIZE, BY BIORESORBABLE STENTS, 2025-2032 (USD MILLION)
  • TABLE 181. AMERICAS LUNG STENTS MARKET SIZE, BY POLYMER STENTS, 2018-2024 (USD MILLION)
  • TABLE 182. AMERICAS LUNG STENTS MARKET SIZE, BY POLYMER STENTS, 2025-2032 (USD MILLION)
  • TABLE 183. AMERICAS LUNG STENTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 184. AMERICAS LUNG STENTS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 185. AMERICAS LUNG STENTS MARKET SIZE, BY TUMOR, 2018-2024 (USD MILLION)
  • TABLE 186. AMERICAS LUNG STENTS MARKET SIZE, BY TUMOR, 2025-2032 (USD MILLION)
  • TABLE 187. AMERICAS LUNG STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 188. AMERICAS LUNG STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 189. AMERICAS LUNG STENTS MARKET SIZE, BY POLYMER-BASED, 2018-2024 (USD MILLION)
  • TABLE 190. AMERICAS LUNG STENTS MARKET SIZE, BY POLYMER-BASED, 2025-2032 (USD MILLION)
  • TABLE 191. AMERICAS LUNG STENTS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. AMERICAS LUNG STENTS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. AMERICAS LUNG STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 194. AMERICAS LUNG STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA LUNG STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. NORTH AMERICA LUNG STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA LUNG STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 198. NORTH AMERICA LUNG STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA LUNG STENTS MARKET SIZE, BY BIORESORBABLE STENTS, 2018-2024 (USD MILLION)
  • TABLE 200. NORTH AMERICA LUNG STENTS MARKET SIZE, BY BIORESORBABLE STENTS, 2025-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA LUNG STENTS MARKET SIZE, BY POLYMER STENTS, 2018-2024 (USD MILLION)
  • TABLE 202. NORTH AMERICA LUNG STENTS MARKET SIZE, BY POLYMER STENTS, 2025-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA LUNG STENTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 204. NORTH AMERICA LUNG STENTS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA LUNG STENTS MARKET SIZE, BY TUMOR, 2018-2024 (USD MILLION)
  • TABLE 206. NORTH AMERICA LUNG STENTS MARKET SIZE, BY TUMOR, 2025-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA LUNG STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 208. NORTH AMERICA LUNG STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA LUNG STENTS MARKET SIZE, BY POLYMER-BASED, 2018-2024 (USD MILLION)
  • TABLE 210. NORTH AMERICA LUNG STENTS MARKET SIZE, BY POLYMER-BASED, 2025-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA LUNG STENTS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. NORTH AMERICA LUNG STENTS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA LUNG STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 214. NORTH AMERICA LUNG STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA LUNG STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. LATIN AMERICA LUNG STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA LUNG STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. LATIN AMERICA LUNG STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA LUNG STENTS MARKET SIZE, BY BIORESORBABLE STENTS, 2018-2024 (USD MILLION)
  • TABLE 220. LATIN AMERICA LUNG STENTS MARKET SIZE, BY BIORESORBABLE STENTS, 2025-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA LUNG STENTS MARKET SIZE, BY POLYMER STENTS, 2018-2024 (USD MILLION)
  • TABLE 222. LATIN AMERICA LUNG STENTS MARKET SIZE, BY POLYMER STENTS, 2025-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA LUNG STENTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 224. LATIN AMERICA LUNG STENTS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 225. LATIN AMERICA LUNG STENTS MARKET SIZE, BY TUMOR, 2018-2024 (USD MILLION)
  • TABLE 226. LATIN AMERICA LUNG STENTS MARKET SIZE, BY TUMOR, 2025-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA LUNG STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 228. LATIN AMERICA LUNG STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 229. LATIN AMERICA LUNG STENTS MARKET SIZE, BY POLYMER-BASED, 2018-2024 (USD MILLION)
  • TABLE 230. LATIN AMERICA LUNG STENTS MARKET SIZE, BY POLYMER-BASED, 2025-2032 (USD MILLION)
  • TABLE 231. LATIN AMERICA LUNG STENTS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. LATIN AMERICA LUNG STENTS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA LUNG STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 234. LATIN AMERICA LUNG STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA LUNG STENTS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA LUNG STENTS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE, MIDDLE EAST & AFRICA LUNG STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE, MIDDLE EAST & AFRICA LUNG STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE, MIDDLE EAST & AFRICA LUNG STENTS MARKET SIZE, BY BIORESORBABLE STENTS, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE, MIDDLE EAST & AFRICA LUNG STENTS MARKET SIZE, BY BIORESORBABLE STENTS, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA LUNG STENTS MARKET SIZE, BY POLYMER STENTS, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA LUNG STENTS MARKET SIZE, BY POLYMER STENTS, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA LUNG STENTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA LUNG STENTS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA LUNG STENTS MARKET SIZE, BY TUMOR, 2018-2024 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA LUNG STENTS MARKET SIZE, BY TUMOR, 2025-2032 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA LUNG STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA LUNG STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA LUNG STENTS MARKET SIZE, BY POLYMER-BASED, 2018-2024 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA LUNG STENTS MARKET SIZE, BY POLYMER-BASED, 2025-2032 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA LUNG STENTS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA LUNG STENTS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA LUNG STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA LUNG STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 255. EUROPE LUNG STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. EUROPE LUNG STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPE LUNG STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPE LUNG STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPE LUNG STENTS MARKET SIZE, BY BIORESORBABLE STENTS, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPE LUNG STENTS MARKET SIZE, BY BIORESORBABLE STENTS, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPE LUNG STENTS MARKET SIZE, BY POLYMER STENTS, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPE LUNG STENTS MARKET SIZE, BY POLYMER STENTS, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPE LUNG STENTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPE LUNG STENTS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPE LUNG STENTS MARKET SIZE, BY TUMOR, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPE LUNG STENTS MARKET SIZE, BY TUMOR, 2025-2032 (USD MILLION)
  • TABLE 267. EUROPE LUNG STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 268. EUROPE LUNG STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 269. EUROPE LUNG STENTS MARKET SIZE, BY POLYMER-BASED, 2018-2024 (USD MILLION)
  • TABLE 270. EUROPE LUNG STENTS MARKET SIZE, BY POLYMER-BASED, 2025-2032 (USD MILLION)
  • TABLE 271. EUROPE LUNG STENTS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 272. EUROPE LUNG STENTS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 273. EUROPE LUNG STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 274. EUROPE LUNG STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 275. MIDDLE EAST LUNG STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. MIDDLE EAST LUNG STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 277. MIDDLE EAST LUNG STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 278. MIDDLE EAST LUNG STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 279. MIDDLE EAST LUNG STENTS MARKET SIZE, BY BIORESORBABLE STENTS, 2018-2024 (USD MILLION)
  • TABLE 280. MIDDLE EAST LUNG STENTS MARKET SIZE, BY BIORESORBABLE STENTS, 2025-2032 (USD MILLION)
  • TABLE 281. MIDDLE EAST LUNG STENTS MARKET SIZE, BY POLYMER STENTS, 2018-2024 (USD MILLION)
  • TABLE 282. MIDDLE EAST LUNG STENTS MARKET SIZE, BY POLYMER STENTS, 2025-2032 (USD MILLION)
  • TABLE 283. MIDDLE EAST LUNG STENTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 284. MIDDLE EAST LUNG STENTS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 285. MIDDLE EAST LUNG STENTS MARKET SIZE, BY TUMOR, 2018-2024 (USD MILLION)
  • TABLE 286. MIDDLE EAST LUNG STENTS MARKET SIZE, BY TUMOR, 2025-2032 (USD MILLION)
  • TABLE 287. MIDDLE EAST LUNG STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 288. MIDDLE EAST LUNG STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 289. MIDDLE EAST LUNG STENTS MARKET SIZE, BY POLYMER-BASED, 2018-2024 (USD MILLION)
  • TABLE 290. MIDDLE EAST LUNG STENTS MARKET SIZE, BY POLYMER-BASED, 2025-2032 (USD MILLION)
  • TABLE 291. MIDDLE EAST LUNG STENTS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 292. MIDDLE EAST LUNG STENTS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 293. MIDDLE EAST LUNG STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 294. MIDDLE EAST LUNG STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 295. AFRICA LUNG STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 296. AFRICA LUNG STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 297. AFRICA LUNG STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 298. AFRICA LUNG STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 299. AFRICA LUNG STENTS MARKET SIZE, BY BIORESORBABLE STENTS, 2018-2024 (USD MILLION)
  • TABLE 300. AFRICA LUNG STENTS MARKET SIZE, BY BIORESORBABLE STENTS, 2025-2032 (USD MILLION)
  • TABLE 301. AFRICA LUNG STENTS MARKET SIZE, BY POLYMER STENTS, 2018-2024 (USD MILLION)
  • TABLE 302. AFRICA LUNG STENTS MARKET SIZE, BY POLYMER STENTS, 2025-2032 (USD MILLION)
  • TABLE 303. AFRICA LUNG STENTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 304. AFRICA LUNG STENTS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 305. AFRICA LUNG STENTS MARKET SIZE, BY TUMOR, 2018-2024 (USD MILLION)
  • TABLE 306. AFRICA LUNG STENTS MARKET SIZE, BY TUMOR, 2025-2032 (USD MILLION)
  • TABLE 307. AFRICA LUNG STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 308. AFRICA LUNG STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 309. AFRICA LUNG STENTS MARKET SIZE, BY POLYMER-BASED, 2018-2024 (USD MILLION)
  • TABLE 310. AFRICA LUNG STENTS MARKET SIZE, BY POLYMER-BASED, 2025-2032 (USD MILLION)
  • TABLE 311. AFRICA LUNG STENTS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 312. AFRICA LUNG STENTS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 313. AFRICA LUNG STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 314. AFRICA LUNG STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 315. ASIA-PACIFIC LUNG STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 316. ASIA-PACIFIC LUNG STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 317. ASIA-PACIFIC LUNG STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 318. ASIA-PACIFIC LUNG STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 319. ASIA-PACIFIC LUNG STENTS MARKET SIZE, BY BIORESORBABLE STENTS, 2018-2024 (USD MILLION)
  • TABLE 320. ASIA-PACIFIC LUNG STENTS MARKET SIZE, BY BIORESORBABLE STENTS, 2025-2032 (USD MILLION)
  • TABLE 321. ASIA-PACIFIC LUNG STENTS MARKET SIZE, BY POLYMER STENTS, 2018-2024 (USD MILLION)
  • TABLE 322. ASIA-PACIFIC LUNG STENTS MARKET SIZE, BY POLYMER STENTS, 2025-2032 (USD MILLION)
  • TABLE 323. ASIA-PACIFIC LUNG STENTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 324. ASIA-PACIFIC LUNG STENTS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 325. ASIA-PACIFIC LUNG STENTS MARKET SIZE, BY TUMOR, 2018-2024 (USD MILLION)
  • TABLE 326. ASIA-PACIFIC LUNG STENTS MARKET SIZE, BY TUMOR, 2025-2032 (USD MILLION)
  • TABLE 327. ASIA-PACIFIC LUNG STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 328. ASIA-PACIFIC LUNG STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 329. ASIA-PACIFIC LUNG STENTS MARKET SIZE, BY POLYMER-BASED, 2018-2024 (USD MILLION)
  • TABLE 330. ASIA-PACIFIC LUNG STENTS MARKET SIZE, BY POLYMER-BASED, 2025-2032 (USD MILLION)
  • TABLE 331. ASIA-PACIFIC LUNG STENTS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 332. ASIA-PACIFIC LUNG STENTS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 333. ASIA-PACIFIC LUNG STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 334. ASIA-PACIFIC LUNG STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 335. GLOBAL LUNG STENTS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 336. GLOBAL LUNG STENTS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 337. ASEAN LUNG STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 338. ASEAN LUNG STENTS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 339. ASEAN LUNG STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 340. ASEAN LUNG STENTS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 341. ASEAN LUNG STENTS MARKET SIZE, BY BIORESORBABLE STENTS, 2018-2024 (USD MILLION)
  • TABLE 342. ASEAN LUNG STENTS MARKET SIZE, BY BIORESORBABLE STENTS, 2025-2032 (USD MILLION)
  • TABLE 343. ASEAN LUNG STENTS MARKET SIZE, BY POLYMER STENTS, 2018-2024 (USD MILLION)
  • TABLE 344. ASEAN LUNG STENTS MARKET SIZE, BY POLYMER STENTS, 2025-2032 (USD MILLION)
  • TABLE 345. ASEAN LUNG STENTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 346. ASEAN LUNG STENTS MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 347. ASEAN LUNG STENTS MARKET SIZE, BY TUMOR, 2018-2024 (USD MILLION)
  • TABLE 348. ASEAN LUNG STENTS MARKET SIZE, BY TUMOR, 2025-2032 (USD MILLION)
  • TABLE 349. ASEAN LUNG STENTS MARKET SIZE, BY MATERIAL, 2018-2024 (USD MILLION)
  • TABLE 350. ASEAN LUNG STENTS MARKET SIZE, BY MATERIAL, 2025-2032 (USD MILLION)
  • TABLE 351. ASEAN LUNG STENTS MARKET SIZE, BY POLYMER-BASED, 2018-2024 (USD MILLION)
  • TABLE 352. ASEAN LUNG STENTS MARKET SIZE, BY POLYMER-BASED, 2025-2032 (USD MILLION)
  • TABLE 353. ASEAN LUNG STENTS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 354. ASEAN LUNG STENTS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
  • TABLE 355. ASEAN LUNG STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 356. ASEAN LUNG STENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 357. GCC LUNG STENTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)

TABLE 358.